BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler
Dr. Abraham Morgentaler
Because they knew about it, or some of them may have been on it before their cancer diagnosis, and they knew how much better they felt. And in the end, I was also giving it to men with metastatic disease and biochemical recurrence. So in 2021, I think it was, we published on 20, 22 guys. who had either biochemical recurrence of their cancer or frank metastatic disease.
0
💬
0
Comments
Log in to comment.
There are no comments yet.